Filter
137
Filtered Results: 137
Text search:
Novartis
Featured
Recommendations
11
New Publications
25
Language
Document type
No document type
66
Studies & Reports
44
Guidelines
14
Strategic & Response Plan
7
Situation Updates
2
Fact sheets
2
Manuals
1
Resource Platforms
1
Countries / Regions
Global
9
Africa
6
South Africa
6
Tanzania
5
India
4
Russia
3
Indonesia
3
Ukraine
2
Ghana
2
Nigeria
2
Philippines
2
Cambodia
2
Latin America and the Carribbean
2
Germany
2
Western and Central Europe
2
Nepal
1
Kenya
1
Sierra Leone
1
Chile
1
Malawi
1
Mozambique
1
Asia
1
Venezuela
1
Bangladesh
1
Brazil
1
Namibia
1
Ethiopia
1
Authors & Publishers
Publication Years
Category
Countries
36
Public Health
16
Clinical Guidelines
9
Pharmacy & Technologies
7
Women & Child Health
1
Key Resources
1
Toolboxes
Mental Health
27
NCDs
24
NTDs
19
COVID-19
7
TB
6
Pharmacy
6
AMR
5
Disability
4
Planetary Health
4
Global Health Education
3
Rapid Response
2
HIV
2
Ebola
2
Caregiver
2
Refugee
1
Cardiovascular diseases (CVDs) have collectively remained the leading causes of death worldwide and substantially contribute to loss of health and excess health system costs. The Global Burden of Diseases, Injuries, and Risk Factors (GBD) Study has tracked trends in death and disability since 1990 a...
Socioeconomic status is associated with differences in risk factors for cardiovascular disease incidence and outcomes, including mortality. However, it is unclear whether the associations between cardiovascular disease and common measures of socioeconomic status—wealth and education—differ among...
sthma prevalence is increasing worldwide, and surveys indicate that most patients in developed and developing countries, including South Africa, do not receive optimal care and are therefore not well controlled. Standard management guidelines adapted to in-country realities are important to support ...
Asthma is the most common chronic respiratory disease among school-going adolescents worldwide. However, the burden of severe asthma is highest in Sub-Saharan Africa. This study aimed to explore teachers’ perceptions of asthma care across six African countries. We conducted focus group discussions...
Little is known about asthma control in the rising number of African children who suffer from this condition. The Achieving Control of Asthma in Children in Africa (ACACIA) study is an observational study collecting evidence about paediatric asthma in urban areas of Ghana, Malawi, Nigeria, South Afr...
This study identifies barriers and provides recommendations to improve asthma care in children across sub-Saharan Africa, where qualitative data is lacking despite high rates.
Over the past 20 years, the Global Initiative for Asthma (GINA) has regularly published and annually updated a global strategy for asthma management and prevention that has formed the basis for many national guidelines. However, uptake of existing guidelines is poor. A major revision of the GINA r...
Asthma is the most common non-communicable disease in children and remains one of the most common throughout the life course. The great majority of the burden of this disease is seen in low-income and middle-income countries (LMICs), which have disproportionately high asthma-related mortality relati...
Asthma is the most common noncommunicable disease in children, and among the most common in adults. According to the most recent estimates from the Global Asthma Network Phase I study, around one in 10 children and adults have symptoms of asthma and one in 20 school-aged children have severe asthma ...
Asthma is the commonest chronic childhood disease and encompasses a spectrum of airway diseases with similar symptoms. Inaccurate diagnosis remains common, especially in younger children, with failure to characterize the different “asthmas.” Children worldwide repeatedly suffer symptoms which se...
Asthma is the most common chronic condition in children worldwide. It affects daytime activities, sleep and school attendance and causes anxiety to parents, families and other carers. The quality of asthma diagnosis and management globally still needs substantial improvement. From infancy to the tee...
The Global Strategy for Tuberculosis Research and Innovation will support the efforts of governments and other stakeholders to accelerate TB research and innovation, and improve equitable access to the benefits of research.
Availabl in Arabic, Chinese, English, French, Spanish and Russian
Canadian Journal of Microbiology 25 June 2021 https://doi.org/10.1139/cjm-2020-0572
BACKGROUND. Asthma is a heterogeneous condition characterised by chronic inflammation and variable expiratory airflow limitation, as well as airway reversibility. The burden of asthma in children is increasing in low- and middle-income countries and remains under-recognised and poorly managed.
OBJE...
760 WEEKLY EPIDEMIOLOGICAL RECORD, NOS. 51/52, 20 DECEMBER 2024, pp.760-769. In French and English
Review over the work and challenges of the Nigerian National Agency for Food and Drug Administration and Control (NAFDAC) in combatting counterfeiting of medicines in Nigeria.
